id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-E-1960-0013,FDA,FDA-2019-E-1960,Response to Notice of Final Determination and Requirement for Election of Patent Term Extension Application,Other,Letter(s),2024-08-09T04:00:00Z,2024,8,2024-08-09T04:00:00Z,,2024-08-09T20:42:52Z,,0,0,0900006486612edd
FDA-2019-E-1960-0012,FDA,FDA-2019-E-1960,Certificate Extending Patent Term,Other,Certificate Extending Patent Term,2024-07-31T04:00:00Z,2024,7,2024-07-31T04:00:00Z,,2024-07-31T12:12:14Z,,0,0,0900006486605ee2
FDA-2019-E-1960-0011,FDA,FDA-2019-E-1960,Notice of Final Determination and Requirement for Election,Other,Letter(s),2024-03-18T04:00:00Z,2024,3,2024-03-18T04:00:00Z,,2024-03-18T19:20:06Z,,0,0,090000648647b459
FDA-2019-E-1960-0009,FDA,FDA-2019-E-1960,Requirement for Information Pursuant to 37 CFR 1.750,Other,Letter(s),2024-03-18T04:00:00Z,2024,3,2024-03-18T04:00:00Z,,2024-03-18T19:19:41Z,,0,0,090000648647b9c1
FDA-2019-E-1960-0010,FDA,FDA-2019-E-1960,Response to Requirement for Information Pursuant to 37 CFR 1.750,Other,Response(s),2024-03-18T04:00:00Z,2024,3,2024-03-18T04:00:00Z,,2024-03-18T19:19:54Z,,0,0,090000648647b9d6
FDA-2019-E-1960-0008,FDA,FDA-2019-E-1960,Letter from FDA CDER to U S Patent and Trademark Office,Other,Letter(s),2024-02-05T05:00:00Z,2024,2,2024-02-05T05:00:00Z,,2024-02-05T15:16:14Z,,0,0,09000064863da07b
FDA-2019-E-1960-0007,FDA,FDA-2019-E-1960,Letter from U. S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2024-01-17T05:00:00Z,2024,1,2024-01-17T05:00:00Z,,2024-01-17T19:19:27Z,,0,0,0900006486390176
FDA-2019-E-1960-0006,FDA,FDA-2019-E-1960,Determination of Regulatory Review Period for Purposes of Patent Extension; LOKELMA,Notice,Determinations,2023-02-08T05:00:00Z,2023,2,2023-02-08T05:00:00Z,2023-04-11T03:59:59Z,2024-02-05T15:16:40Z,2023-02667,0,0,090000648563f05a
FDA-2019-E-1960-0005,FDA,FDA-2019-E-1960,Letter from FDA CDER TO U.S. Patent and Trademark Office,Other,Letter(s),2023-02-02T05:00:00Z,2023,2,2023-02-02T05:00:00Z,,2023-02-02T17:34:16Z,,0,0,0900006485627359
FDA-2019-E-1960-0004,FDA,FDA-2019-E-1960,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2022-12-29T05:00:00Z,2022,12,2022-12-29T05:00:00Z,,2022-12-29T21:21:35Z,,0,0,090000648555f86c
FDA-2019-E-1960-0003,FDA,FDA-2019-E-1960,Letter from FDA to U.S. Patent and Trademark Office,Other,Letter(s),2022-05-31T04:00:00Z,2022,5,2022-05-31T04:00:00Z,,2022-05-31T14:57:07Z,,0,0,0900006483d30dc9
FDA-2019-E-1960-0002,FDA,FDA-2019-E-1960,"Patent Extension Application from Arent Fox LLP (on behalf of ZS Pharma, Inc.)",Other,Application,2019-04-24T04:00:00Z,2019,4,2019-04-24T04:00:00Z,,2019-04-24T12:29:16Z,,0,0,0900006483be9e77
FDA-2019-E-1960-0001,FDA,FDA-2019-E-1960,Letter from U.S. Patent and Trademark  Office,Other,Letter(s),2019-04-24T04:00:00Z,2019,4,2019-04-24T04:00:00Z,,2019-04-24T12:25:43Z,,0,0,0900006483be9e46